AIP
TNGX icon

Arrowpoint Investment Partners’s Tango Therapeutics TNGX Stock Holding History

Arrowpoint Investment Partners’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$428K Buy
+20,463
New +$285K 0.38% 46

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Arrowpoint Investment Partners's TNGX Position: Q1 2026 in Review

Arrowpoint Investment Partners opened a new position in Tango Therapeutics (TNGX) in Q1 2026: 20,463 shares worth $428K. The stake represents 0.38% of the portfolio and ranks #46 among its holdings.

194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Arrowpoint Investment Partners held 20,463 shares of Tango Therapeutics worth $428K as of Q1 2026.
  • Tango Therapeutics was a new Arrowpoint Investment Partners position in Q1 2026.
  • Tango Therapeutics made up 0.38% of Arrowpoint Investment Partners's portfolio in Q1 2026, its #46 holding.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Arrowpoint Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.